Dana-Farber Cancer Institute
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Dana-Farber Cancer Institute
Jul 27, 2024, 06:38 |
Blog
The Jimmy Fund - Spotlighting Vinayak Venkataraman this Sarcoma Awareness Month
The Jimmy Fund shared on LinkedIn: “This Sarcoma Awareness Month, we’re spotlighting Vinayak Venkataraman, M.D., of…
Jul 24, 2024, 08:46 |
Blog
Join us to discuss the new cancer hospital proposed by Dana-Farber
Dana-Farber Cancer Institute shared a post on LinkedIn: ''Join us to discuss the new cancer…
Jul 24, 2024, 01:00 |
Blog
Chiara Corti: Over 1,900 downloads for our educational chapter on systemic therapy in breast cancer
Chiara Corti, Research Fellow at Dana-Farber Cancer Institute, shared a post on LinkedIn about a…
Jul 23, 2024, 00:18 |
Blog
Notch signaling in advanced prostate cancer
Himisha Beltran, Associate Professor of Medicine at Dana Farber Cancer Institute, shared a post on…
Jul 22, 2024, 13:38 |
Blog
Toni Choueiri: Excited for PMC2024 where over 7000 riders are focused on 1 mission
Toni Choueiri posted on X: "Last training ride before Pan-Mass Challenge ride on Team More…
Jul 21, 2024, 15:35 |
Blog
Dean Crowe: Exciting to highlight the amazing accomplishments achieved through national advocacy
Dean Crowe, Founder and CEO at the Rally Foundation for Childhood Cancer Research, shared on LinkedIn:…
Jul 21, 2024, 12:10 |
Blog
invIOs selects lead candidate to IND-enable studies in glioblastoma and melanoma
invIOs GmbH (“invIOs”), a privately held biotechnology company developing novel therapies for cancer, announced that…
Jul 21, 2024, 09:48 |
Blog
New adult inpatient cancer hospital in the Longwood Medical Area by Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: "On Wednesday, July 24, 2024, please join…
Jul 20, 2024, 12:06 |
Blog
Andrew Lane: Powerful segment produced by Medical Stories on one of my brave patients at Dana-Farber with BPDCN
Andrew Lane, Associate Chief of Division of Hematologic Neoplasia at Dana-Farber Cancer Institute, shared a post…
Jul 19, 2024, 22:19 |
Insight
Yüksel Ürün: Congratulations all new participants of the ASCO Leadership Development Program!
Yüksel Ürün shared a post by Miriam Knoll, on X, adding: "Congratulations to you and…
Jul 18, 2024, 12:58 |
Blog
2024-2025 Best Hospitals by the U.S. News and World Report
The U.S. News & World Report published its 2024-2025 Best Hospitals rankings, marking the 35th anniversary of…
Jul 18, 2024, 10:05 |
Insight
EMA Joins FDA: Osimerintib + Chemo Approved for EGFR-Mutated Lung Cancer
Breaking News: EMA Joins FDA in Approving Osimerintib with Chemotherapy as a New 1st-Line Treatment…
Jul 16, 2024, 10:50 |
Blog
Social Determinants of Health with Large/Moderate Language Models on EHR Data
NCI Physical Sciences shared a post on X: Social Determinants of Health "On July 30…
Jul 15, 2024, 11:50 |
Blog
Karl Semaan: Renee Maria Saliby presented her results on intermediate endpoints in patients with mRCC at KCRS24
Karl Semaan, Postdoctoral Research Fellow at Dana-Farber Cancer Institute, shared a post on X: "Star…
Jul 15, 2024, 09:22 |
Blog
Craig Bunnell: My 10th Pan-Mass Challenge ride
Craig Bunnell, Chief Medical Officer at Dana-Farber Cancer Institute, shared on LinkedIn: "It's that time of year…
Jul 15, 2024, 06:31 |
Positive
Karl Semaan received the Outstanding Research Award at KCRS24
Sylvan Baca, GU oncologist and computational epigenomics enthusiast at Dana-Farber Cancer Institute, shared on X:…
Jul 13, 2024, 07:56 |
Blog
Oncoinfluencers to Follow on Social Media: Dr. Paolo Tarantino
Our next oncoinfluencer is Dr. Paolo Tarantino. Dr. Tarantino is active on both X/Twitter and…
Jul 12, 2024, 23:29 |
Insight
Clinical Utility of Pre-surgical ctDNA Detection in Early Stage NSCLC
Biagio Ricciuti shared on X: "Clinical Utility of Pre-surgical ctDNA Detection in Early Stage NSCLC…
Jul 12, 2024, 17:04 |
Insight
Red Sox leadership as sports philanthropist of the year by ESPN - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared on LinkedIn: “Since 1953, Boston Red Sox leadership has championed the…
Jul 12, 2024, 16:16 |
Blog
Jun Gong: Thank you Emre Yekedüz for highlighting our study on de novo oligometastatic mHSPC
Jun Gong, Medical oncologist and researcher in gastrointestinal and genitourinary cancers at Cedars-Sinai, shared a…
Jul 11, 2024, 13:02 |
Blog
Khushi Kohli: Disparities in palliative care receipt faced by AANHPI subgroups with cancer
Khushi Kohli, Research Intern at Dana-Farber Cancer Institute, made the following post on X: "Thank…
Jul 10, 2024, 11:57 |
Blog
The 2024 Uromigos Cup
Uromigos formed in early 2017 as a group of friends attempting to provide balanced, scientific content…
Jul 10, 2024, 10:01 |
Blog
Scott Armstrong has been named senior vice president for Drug Discovery and chief research strategy officer at Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared on LinkedIn: "Scott Armstrong has been named senior vice president for Drug Discovery…
Jul 10, 2024, 08:47 |
Blog
Does pregnancy reduce the risk of developing breast or gynecologic cancers? - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on X: “Does pregnancy reduce the risk of developing…
Jul 10, 2024, 08:41 |
Blog
Most recent Breast Cancer Research Digest - Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared on X: "Here's the most recent Breast Cancer Research Digest…
Jul 10, 2024, 02:33 |
Blog
Tribute to Livingston’s many achievements during nearly a half-century at Dana-Farber
Dana-Farber Cancer Institute shared a post on X: “In an outpouring of support and to…
Jul 9, 2024, 06:46 |
Blog
David Cordas dos Santos: Nonrelapse mortality after CAR-T cell treatment
David Cordas dos Santos, PostDoc at Dana-Farber Cancer Institute, made the following post on X:…
Jul 8, 2024, 17:31 |
Insight
Kai Rejeski: Underestimated aspect of CAR T-cell therapy: non-relapse mortality
Kai Rejeski, Visiting investigator at Memorial Sloan Kettering Cancer Center, shared on X: “Hot off…
Jul 6, 2024, 14:44 |
Insight
BAX protein's role in cell death, a promising target for cancer therapy - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: “For years, researchers have explored BAX protein's…
Jul 6, 2024, 14:42 |
Blog
Craig Bunnell has earned distinction as the inaugural Morse Family Chief Medical Officer - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute posted on LinkedIn: "After more than 15 years as a member of…
Jul 6, 2024, 05:36 |
Blog
Kingsley Ndoh: How generative AI will revolutionize cancer care
Kingsley Ndoh, Founder and CEO of the Hurone AI, shared a post on LinkedIn: "I…
Jul 4, 2024, 16:09 |
Blog
A deep dive into immune responses to cancer vaccines plus immunotherapy - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: . "David Reardon, MD, is doing a…
Jul 4, 2024, 15:05 |
Insight
Susanna Greer: Next target - neuroblastoma
Susanna Greer, Chief Scientific Officer at The V Foundation for Cancer Research, shared on LinkedIn: …
Jul 4, 2024, 13:54 |
Blog
How can I reduce my colorectal cancer risk? - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute posted on X: “How can I reduce my colorectal cancer risk? Kimmie…
Jul 4, 2024, 03:24 |
Positive
Peter Obersheimer has been named to the list of Top 10 30-Somethings by the Association of Corporate Counsel
Dana-Farber Cancer Institute shared on LinkedIn: "Peter Obersheimer, Associate General Counsel at Dana-Farber, has been…
Jul 3, 2024, 10:44 |
Blog
Abeid M. Athman Omar: The last four months have been very eventful for me
Abeid M. Athman Omar, Clinical Oncology Specialist at Kenyatta University, shared a post on LinkedIn: "The last…
Jul 3, 2024, 01:24 |
Blog
Paolo Tarantino: ATEMPT would have not been possible without the vision of Sara Tolaney
Sara Tolaney shared a post by Paolo Tarantino on X: “Very lucky to get to…
Jul 2, 2024, 10:32 |
Insight
Trastuzumab emtansine (T-DM1) is highly effective in preventing stage 1 HER2-positive breast cancer from recurring - MedEdge MEA
MedEdge MEA shared a post on LinkedIn: . "A year of treatment with a medicine…
Jul 2, 2024, 08:37 |
Insight
How will we treat breast cancer 10 years from now?
Paolo Tarantino shared an article by Mattea Reinisch et al. on LinkedIn: …
Jul 1, 2024, 15:23 |
Insight
Paolo Tarantino: Final analysis of the ATEMPT phase 2 trial
Paolo Tarantino shared a post on X: “Can ADCs help prevent recurrence from breast cancer…
Jun 30, 2024, 15:45 |
Career
William Kaelin was recognized with the Stanley P. Reimann Honor Award - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute posted on LinkedIn: "William Kaelin Jr., MD, physician, scientist, and Nobel laureate, was…
Jun 30, 2024, 07:03 |
Blog
Rebecca L. Zon recieves Physician-Scientist Training Award from the Damon Runyon Cancer Research Foundation - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: “Congratulations to Dana-Farber’s Rebecca L. Zon, MD…
Jun 30, 2024, 02:46 |
Blog
Dana-Farber Cancer Institute - William Kaelin Jr. was recognized with the Stanley P. Reimann Honor Award
Dana-Farber Cancer Institute shared on LinkedIn: "William Kaelin Jr., MD, physician, scientist, and Nobel laureate, was recognized…
Jun 29, 2024, 10:28 |
Societies
The perfect is the enemy of the good
Elad Sharon, Medical Oncologist at Dana-Farber Cancer Institute, shared on X: "“The perfect is the…
Jun 29, 2024, 04:10 |
Blog
Dana-Farber's first Young Adult patient navigator, Meghan Donovan
Dana-Farber Cancer Institute shared a post on LinkedIn: “Behind the resource desk in the new HomeGoods…
Jun 28, 2024, 12:15 |
Insight
Talal El Zarif: Non-invasive detection of small cell transformation in EGFRm lung adenocarcinoma through epigenomic cfDNA profiling
Talal El Zarif, Research Fellow at Dana-Farber Cancer Institute, shared a post on X: .…
Jun 28, 2024, 11:28 |
Societies
Keynote address by Myriam Chalabi at ESMOGI24
Toni Choueiri shared on X: "Keynote address at ESMOGI24 with superstar Myriam Chalabi- Immunotherapy for…
Jun 26, 2024, 05:00 |
Blog
Lachelle Dawn: Fellows can join the Dana Farber’s division of Leukemia
Lachelle Dawn, Hematologist and Scientist at Dana-Farber Cancer Institute, shared on X: “I work with…
Jun 26, 2024, 03:41 |
Insight
Paolo Tarantino: Opportunities to improve outcomes for early recurrent TNBC
Paolo Tarantino shared a post on X: . "Early recurrent TNBC (Triple-Negative…
Jun 26, 2024, 03:18 |
Insight
Paolo Tarantino: The 5 S rules help memorizing a simple framework to manage ILD
Paolo Tarantino shared on LinkedIn: “T-DXd is rapidly expanding in indications, from HER2+, to HER2-low, and…
Jun 23, 2024, 13:08 |
Drugs
Capivasertib is now approved in EU for HR+/HER2- breast cancer
Paolo Tarantino shared a post on X: "Capivasertib is now approved in EU for the…
Jun 21, 2024, 19:33 |
Blog
Key advances in the effort to harness NK cells at Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: “Natural Killer (NK) cells are potent first…
Jun 21, 2024, 09:35 |
Blog
Harold J. Burstein: Course on multidisciplinary care of breast cancer in early and late stages
Harold J. Burstein, Breast cancer specialist and professor at Dana Farber Cancer Institute, shared on…
Jun 21, 2024, 04:15 |
Insight
Biagio Ricciuti: Fusion partners and chromosomal breakpoints of oncogenic fusions are not stochastic
Giannis Mountzios, Medical Oncologist at the Department of Medical Oncology in the Air Force General…
Jun 19, 2024, 15:23 |
Blog
Dana-Farber Cancer Institute is proud to announce the Direct Connect Partnership with Massachusetts Firefighters
Dana-Farber Cancer Institute posted on LinkedIn: "Dana-Farber Cancer Institute is proud to announce the Direct…
Jun 19, 2024, 12:39 |
Blog
Toni Choueiri: Highly recommend this Master Class on Cancer
Toni Choueiri shared on X: "I very much enjoyed (between EURo2024 games) this dialogue between…
Jun 16, 2024, 14:36 |
Blog
Jennifer Marks: Closing this chapter with Georgetown Hematology/Oncology Fellowship
Narjust Florez shared a post by Jennifer Marks, Hematologist and Oncologist at MedStar Georgetown University Hospital, on X:…
Jun 15, 2024, 14:42 |
Blog
Cancer Comunity Letter on eliminating menthol as a characterizing flavor in cigarettes - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: “Dana-Farber recently signed a letter imploring President Biden…
Jun 14, 2024, 14:50 |
Blog
Thejus Jayakrishnan: Thank you James Cleary for the opportunity to work on the review with you!
Thejus Jayakrishnan, Hematology/Oncology Fellow at Cleveland Clinic, shared a post by James Cleary, Gastrointestinal Oncologist…
Jun 14, 2024, 13:52 |
Blog
Maria Vidal: Grateful to Ann Partridge and her team at DFCI for this amazing opportunity
Maria Vidal, Medical Oncologist at Hospital Clinic and IOB Institute of Oncology Barcelona, shared a…
Jun 14, 2024, 03:59 |
Blog
Wafik S. El-Deiry: Great to have Dr. Tao Zou visiting the Legorreta Cancer Center
Wafik S. El-Deiry shared a post on X: “Great to have physician-scientist and thoracic medical oncologist…
Jun 13, 2024, 17:10 |
Positive
Pamela Contreras Chavez: I am a clinician who will focus on hematology bilingual care in Chicago
Pamela Contreras Chavez, Hematology-Oncology Fellow at Dana-Farber Cancer Institute, shared on X: "I made it!…
Jun 12, 2024, 23:29 |
Blog
Dana-Farber nurses at this year's Nursing and Patient Care Services Scholarship Week
Dana-Farber Cancer Institute shared a post on LinkedIn: "Dana-Farber nurses' commitment to research was recently…
Jun 12, 2024, 12:58 |
Blog
Christopher Lathan has been selected to be part of the 2024 Living Histories of Color in Hyde Park exhibit - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: “Christopher Lathan, MD, MS, MPH, director of the…
Jun 12, 2024, 05:47 |
Blog
Timothy Rebbeck: Rest in power Lyn Denny
Nirmala Bhoo Pathy shared a post on LinkedIn by Timothy Rebbeck, Professor at Dana-Farber Cancer Institute…
Jun 11, 2024, 15:21 |
Blog
Abeid M. Athman Omar: Delighted to have received two awards at the ASCO24 meeting
Abeid M. Athman Omar, Clinical Oncology Specialist at Kenyatta University, shared a post on LinkedIn: ''I am…
Jun 11, 2024, 09:20 |
Blog
Toni Choueiri: Ocean side ride with Team More Cowbell in preparation for PMC2024
Toni Choueiri shared a post on LinkedIn: ''Beautiful ocean side ride with Team More Cowbell…
Jun 11, 2024, 01:42 |
Blog
Cancer Research Institute's 2024 Spanish-Language Immunotherapy Patient Summit
Quoting Cancer Research Institute (CRI) on LinkedIn: "Featuring Spanish-speaking patients and medical experts, including Dr. Eduardo M.…
Jun 10, 2024, 08:30 |
Career
Kathrin Dvir: Grateful to my mentors, colleagues, and patients at Dana-Farber for making me a medical oncologist
Kathrin Dvir, Chief Fellow Hematology-Oncology at Dana-Farber Cancer Institute, shared a post on X: "Fellowship…
Jun 9, 2024, 16:20 |
Insight
Sheheryar Kabraji: Look at how ER low tumors behave
Sheheryar Kabraji, Associate Professor at Roswell Park Comprehensive Cancer Center, shared on X/Twitter: "! Very cool…
Jun 9, 2024, 09:13 |
Blog
Dana-Farber Cancer Institute - The Ge Li and Ning Zhao Family Foundation has made an extraordinary gift of $10 million to Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: "The Ge Li and Ning Zhao Family Foundation…
Jun 9, 2024, 02:45 |
Insight
Brian Rini: KIM-1 is a novel prognostic and predictive biomarker in RCC
Toni Choueiri shared a post by Brian Rini, Chief of Clinical Trials at Vanderbilt University, on X/Twitter:…
Jun 8, 2024, 02:16 |
Blog
Kornelia Polyak has been elected to the 2024 class of the American Academy of Arts and Sciences - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: “Kornelia Polyak, co-leader of the Dana-Farber Harvard Cancer…
Jun 8, 2024, 02:16 |
Blog
Toni Choueiri: NICHE-2 by Myriam Chalabi published in NEJM
Toni Choueiri shared a post on X: , "NICHE-2 published…
Jun 6, 2024, 10:29 |
Societies
Jia Luo: Thankful for my smart and talented colleagues who gave brilliant talks at ASCO24
Jia Luo, Thoracic Medical Oncologist and Cancer Researcher at Dana-Farber Cancer Institute, recently shared a…
Jun 6, 2024, 07:26 |
Career
Three physician-researchers have been named to leadership positions at ASCO - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: “Three physician-researchers have been named to leadership…
Jun 6, 2024, 00:37 |
Blog
Toni Choueiri: We appreciate Robin Zon being "one of us"
Toni Choueiri shared on LinkedIn: . "We (soccer fans at…
Jun 5, 2024, 11:01 |
Insight
Toni Choueiri: Amazing ASCO24!
Toni Choueiri shared a post on LinkedIn: “Amazing ASCO24! Thank you Lynn Schuchter, Angela DeMichele, and…
Jun 4, 2024, 12:43 |
Insight
Chiara Corti: DESTINY-Breast06 results presented by G Curigliano
Chiara Corti, Research Fellow at Dana-Farber Cancer Institute, shared a post on X: “DESTINY-Breast06 results…
Jun 4, 2024, 09:20 |
Insight
Marc Eid: Come check Poster Board 224 by Talal El Zarif and Karl Semaan at ASCO24
Marc Eid, Postdoctoral research fellow in Medical Oncology at the Dana-Farber Cancer Institute, shared on…
Jun 3, 2024, 16:29 |
Blog
Renee Maria Saliby: Brilliant presentation and work led by Soki Kashima
Renee Maria Saliby, Postdoctoral GU Oncology Research Fellow at Dana-Farber Cancer Institute, shared a post on X:…
Jun 2, 2024, 12:08 |
Blog
Don’t miss the Helen Gurley Brown Presidential Summit on Women and Science at Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared on their X: "Don’t miss the Helen Gurley Brown Presidential Summit…
Jun 2, 2024, 11:56 |
Blog
Margaret Shipp has been inducted into the Giants of Cancer Care Program - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared on LinkedIn: "Congratulations to Dana-Farber Cancer Institute’s Margaret Shipp, MD, who…
Jun 2, 2024, 09:48 |
Insight
Ahmed Elkhanany: Inspiring talks by Rafeh Naqash and Arya Roy in their US journeys
Ahmed Elkhanany, Assistant Professor of Breast Oncology at Dan L Duncan Comprehensive Cancer Center, shared…
Jun 2, 2024, 09:43 |
Insight
Marc Machaalani: Success stories of IMGs at the IMG Oncologists Community of Practice meeting
Marc Machaalani, Postdoctoral Research Fellow at Dana-Farber Cancer Institute, shared a post on X: “Truly…
Jun 1, 2024, 23:46 |
Blog
Wenxin Xu: AI models can accurately impute performance status from clinical notes
Wenxin Xu, Genitourinary oncologist and clinical cancer researcher at Dana-Farber Cancer Institute and Assistant Professor…
Jun 1, 2024, 06:37 |
Career
Joel Katz will join Dana-Farber as Senior Vice President for Education
Dana-Farber Cancer Institute shared a post on LinkedIn: "We are pleased to share that Joel Katz,…
May 31, 2024, 16:03 |
Blog
Herbert Loong: COR2ED international webinar on the importance of biomarker testing in lung cancer and prostate cancer
Herbert Loong shared on LinkedIn: . "Throwback to a recent COR2ED international webinar…
May 31, 2024, 15:41 |
Societies
Paolo Tarantino: More than 25 ASCO24 oral presentations by Dana-Farber Cancer Institute researchers
Paolo Tarantino shared a post by Dana-Farber Cancer Institute on X: "More than 25 ASCO24…
May 31, 2024, 13:48 |
Blog
Dana-Farber researchers and faculty made an impressive showing at this year's ASTCT Meeting
Dana-Farber Cancer Institute shared on their LinkedIn: . "Dana-Farber researchers and faculty made an impressive showing…
May 31, 2024, 02:35 |
Blog
Biagio Ricciuti: Great conversation on the role of ICI in patients with NSCLC and driver mutations
Biagio Ricciuti shared a post by Narjust Florez on X, adding: , "I had a…
May 29, 2024, 08:50 |
Blog
Shushan Hovsepyan: Some oral abstract sessions in pediatric oncology to keep on your radar at ASCO 2024
Shushan Hovsepyan shared a post on LinkedIn: "ASCO 2024 is just around the corner and here…
May 28, 2024, 14:34 |
Drugs
Paolo Tarantino: Impressive activity with tucatinib plus trastuzumab for HER2-mutated breast cancer
Paolo Tarantino shared on X: "Impressive activity with tucatinib plus trastuzumab for HER2-mutated breast cancer.…
May 28, 2024, 13:01 |
Blog
Wendy Chen highlights recommended limits for alcohol consumption - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared on X: "What's the association between drinking alcohol and cancer? Wendy…
May 28, 2024, 08:15 |
Blog
The First Annual Jerry Ritz Symposium on Cellular Therapies - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared on LinkedIn: ''The Jimmy Fund Auditorium was filling fast last month,…
May 28, 2024, 07:49 |
Insight
Tom Powles: Renal cancer highlights at ASCO24 - KIM1 biomarker data stands out
Toni Choueiri shared a post by Tom Powles, Director of Barts Cancer Center, on X and…
May 28, 2024, 01:03 |
Insight
Toni Choueiri: First Pan-Mass Challenge training ride
Toni Choueiri shared a post on LinkedIn: “First Pan-Mass Challenge training ride. Amazing scenery! Only 25…
May 26, 2024, 06:02 |
Insight
Toni Choueiri: The work of Eddy Saad, Eli Van Allen, Sasha Gusev being highlighted here at ASCO24
Toni Choueiri shared a post by Neeraj Agarwal on X/Twitter: "The work of Eddy Saad, Eli Van…
May 25, 2024, 14:28 |
Blog
Studies conducted by Dana-Farber at this year’s AACR Annual Meeting
Dana-Farber Cancer Institute shared on LinkedIn: "Numerous studies conducted by Dana-Farber researchers show promising results for…
May 25, 2024, 14:20 |
Blog
Marc Machaalani: Immunotherapy rechallenge after prior immune checkpoint inhibition in mRCC
Marc Machaalani, Postdoctoral Research Fellow at Dana-Farber Cancer Institute, shared a post by ASCO on…
1
2
3
All:
264
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube